The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. Scientists at Liverpool identified a particularly virulent strain of the bacteria that…
Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza
Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project “FLUCURE” supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases…
Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference
NanoViricides, Inc. (OTC BB: NNVC.OB) (the “Company”) announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company’s anti-viral technology and…
Stripe of Gennari in the blind may play greater role in processing tactile stimuli
The Stripe of Gennari develops even in those who are blind from birth and does not degenerate, despite a lack of visual input. This was discovered by Robert Trampel and colleagues from…
Biomoda completes sample collection in pilot study of CyPath diagnostic assay for lung cancer
Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its…
Aspirin for coronary heart prevention is less costly, more effective
Using aspirin for coronary heart prevention is less costly and more effective than doing nothing in men older than 45 with more than 10 percent 10-year-risk of the disease, according to a…
Hemoglobin A1c is not a reliable test to diagnose diabetes in children
Doctors are increasingly using a convenient blood glucose test for diagnosing diabetes and pre-diabetes, but a study by the University of Michigan’s C.S. Mott Children’s Hospital shows it’s not the best way…
Positive results from Harbor BioSciences’ Triolex initial preclinical study for treatment of PD
Harbor BioSciences, Inc. (OTCBB:HRBR), which is investigating the use the company’s proprietary compound Triolex® as a treatment for Parkinson’s disease (PD) with funding from The Michael J. Fox Foundation (MJFF), announced positive…
Antibody-directed chemotherapy may be effective for majority of younger AML sufferers
Antibody-directed chemotherapy offers improved survival to particular sub-groups of leukaemia sufferers, a Cardiff University-led study has found. The findings suggest that the treatment may be effective for the majority of younger acute…
New study provides insight into brain activity of depressed women responding to crying infants
Mothers who are depressed respond differently to their crying babies than do non-depressed moms. In fact, their reaction, according to brain scans at the University of Oregon, is much more muted than…
IAEA chooses Dubai Hospital as its permanent training venue in the Middle East
The experts at the International Atomic Energy Agency (IAEA) has recommended to adopt Dubai Hospital as the permanent premises for various training programs and workshops IAEA will organise time to time in…
Breakthrough in Huntington’s disease may give patients hope for cure
A huge leap forward in understanding Huntington’s disease may give patients hope for a cure. Laboratory tests on skin cells and post-mortem brain tissue of Huntington’s disease patients determined that an overactive…
Higher intake of vitamin D may reduce breast cancer risk
Researchers at the University of California, San Diego School of Medicine and Creighton University School of Medicine in Omaha have reported that markedly higher intake of vitamin D is needed to reach…
Drug developed for controlling cholesterol synthesis can kill human breast cancer cells
A University of Missouri researcher believes there could be a new drug compound that could kill breast cancer cells. The compound might also help with controlling cholesterol. Salman Hyder, the Zalk Endowed…
Prolonged use of osteoporosis drugs may increase risk of unusual fractures in women
However, the drugs do prevent hip fractures Women who take commonly prescribed drugs for osteoporosis known as bisphosphonates for five years or more may be at higher risk of certain kinds of…